Beta Bionics, Inc. (BBNX) Soars 10.3%: Is Further Upside Left in the Stock? [Yahoo! Finance]
Beta Bionics, Inc. (BBNX)
Company Research
Source: Yahoo! Finance
This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 11% gain over the past four weeks. Beta Bionics scored a strong price increase, on investors' optimism surrounding its impending first-quarter 2026 financial results, which is slated to release on April 21 post the closing bell. In the previous quarter, the company's revenues rose 57% year over year, supported by a staggering 295% rise in the Pharmacy Benefit Plan (PBP) channel net sales. This company is expected to post quarterly loss of $0.53 per share in its upcoming report, which represents a year-over-year change of -1.9%. Revenues are expected to be $27.75 million, up 57.3% from the year-ago quarter. While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price mov
Show less
Read more
Impact Snapshot
Event Time:
BBNX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BBNX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BBNX alerts
High impacting Beta Bionics, Inc. news events
Weekly update
A roundup of the hottest topics
BBNX
News
- Beta Bionics (BBNX) was downgraded by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from "sell (d-)" to "sell (e+)".MarketBeat
- Beta Bionics (BBNX) had its price target lowered by Leerink Partners from $25.00 to $24.00. They now have an "outperform" rating on the stock.MarketBeat
- Beta Bionics (BBNX) had its price target lowered by Stifel Nicolaus from $22.00 to $20.00. They now have a "buy" rating on the stock.MarketBeat
- Beta Bionics projects $131M-$136M 2026 revenue and raises gross margin outlook to 57.5%-59.5% [Seeking Alpha]Seeking Alpha
- Beta Bionics, Inc. (BBNX) Reports Q1 Loss, Misses Revenue Estimates [Yahoo! Finance]Yahoo! Finance
BBNX
Earnings
- 4/21/26 - Beat
BBNX
Sec Filings
- 4/21/26 - Form 10-Q
- 4/21/26 - Form 8-K
- 4/10/26 - Form ARS
- BBNX's page on the SEC website